VASO Corp (VASO) stock
Close on Oct 19, 2026Market cap $51.17MP/E 29.0Yield –
VASO Corp grew revenue 3.4% to $80.22M over the twelve months to Jun 30, 2026. At the latest close the market valued the company at $51.17M, 29.0 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $51.17M
- P/E ratio
- 29.0
- Price to sales
- 0.64
- Price to book
- 1.75
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $80.22M
- Net income
- $2.50M
- EPS, diluted
- $0.01
- Book value per share
- $0.17
- Diluted shares
- 176M
Trading
- Previous close
- $0.29
- Open
- $0.28
- Day's range
- $0.28 – $0.29
- Volume
- 4,503
- Average volume (20 days)
- 114,332
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | VASO | S&P 500 | Difference | VASO per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -1.6% | +0.6% | −2.2 pts | ||
| 3 months | +47.9% | +3.4% | +44.6 pts | ||
| Year to date | +65.9% | +13.3% | +52.6 pts | ||
| 1 year | +149.1% | +16.6% | +132.5 pts | ||
| 3 years | -9.3% | +86.4% | −95.7 pts | -3.2% | +23.1% |
| 5 years | +383.6% | +81.9% | +301.8 pts | +37.1% | +12.7% |
| 10 years | +93.4% | +318.9% | −225.4 pts | +6.8% | +15.4% |
Fifteen years at a glance
Fiscal years 2010 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases VASO filed with the SEC as exhibits to Form 8-K or 6-K
About VASO
Electromedical & Electrotherapeutic Apparatus
Vaso Corporation operates in the healthcare equipment and information technology sectors through three business segments. Its IT segment provides managed network infrastructure, transport, and network security services. The professional sales service segment serves as an exclusive representative selling GE HealthCare diagnostic imaging equipment, ultrasound systems, service contracts, and training to healthcare providers in the middle market. Its medical equipment segment designs, manufactures, and services cardiovascular diagnostic and therapeutic products. These offerings include ambulatory blood pressure and ECG monitors, physiological analysis software, wireless vital-sign monitors, and external counterpulsation therapy systems.
Company profile, executives and historyVASO stock: common questions
What is VASO's stock price?
VASO closed at $0.29 on Oct 19, 2026, up 0.06% on the day.
What is VASO's market cap?
VASO was worth $51.17M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is VASO's P/E ratio?
VASO trades at 29.0 times earnings, based on diluted earnings per share of $0.01 over the twelve months to Jun 30, 2026.
How much revenue does VASO make?
VASO reported revenue of $80.22M for the twelve months to Jun 30, 2026, up 3.4% from a year earlier.
Does VASO pay a dividend?
No. VASO has not paid a cash dividend over the last twelve months.
How has VASO stock performed over the past year?
Including dividends, VASO returned +149.1% over the past year, against +16.6% for the S&P 500.
Who are VASO's competitors?
Companies most similar to VASO by business, industry and size include FOCL, ELMD, APYX, ESMC, IRMD.
See a number that looks wrong?